Clinical trial
A Phase I Trial of Ascorbic Acid and Gemcitabine for the Treatment of Metastatic Pancreatic Cancer
NCT01049880 is registered in ClinicalTrials.gov with Joseph J. Cullen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Trial of Ascorbic Acid and Gemcitabine for the Treatment of Metastatic Pancreatic Cancer
- Lead sponsor
- Joseph J. Cullen
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- March 31, 2013
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.